definiens: means : ( i ) the manufacturing related Assets listed or describedon Schedule 1.1(35)(i ) ; ( ii ) the Intellectual Property listed or described on Schedule 1.1(35)(ii ) ; ( iii ) theContracts listed or described on Schedule 1.1(35)(iii ) ; ( iv ) all cash and cash equivalents, except to theextent expressly allocated to the [COMPANY] Group pursuant to Section 2.11 ; ( v ) any and all BioverativProduct Drug Substance ( as defined in the Manufacturing and Supply Agreement ) inventory and otherraw materials used in the manufacture of [COMPANY] Product Drug Product ( as defined in theManufacturing and Supply Agreement ) held by or for the account of [COMPANY] or any of its Subsidiariesimmediately prior to the Distribution Effective Time ; ( vi ) subject to the rights of the [COMPANY] Grouppursuant to Article IX, all Policies binders and claims and rights thereunder and all prepaid insurancepremiums ( other than any insurance policies acquired prior to the Distribution Effective Time directly byand in the name of [COMPANY] or a member of the [COMPANY] Group ) ; ( vii ) any and all work papers ofBiogen ’s auditors and any other Tax records ( including accounting records ) of any [COMPANY] Groupmember ( which will be addressed in the Tax Matters Agreement ) ; and ( viii ) any and all Assets that areexpressly contemplated by this Agreement or any Ancillary Agreement ( or the Schedules hereto orthereto ) as Assets which have been or are to be retained by, or Transferred to, any member of theBiogen Group